Cargando…

COVID-19 and the importance of effective risk communication with children

During the current COVID-19 pandemic, effective risk communication is essential to mitigate the mental health impact on children and their families. Effective risk communication involves being honest but yet reassuring, framing issues in an actionable way, and modeling realistically reassuring commu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abrams, Elissa M, Shaker, Marcus, Greenhawt, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126270/ https://www.ncbi.nlm.nih.gov/pubmed/35620559 http://dx.doi.org/10.1093/pch/pxab101

Ejemplares similares

Allergists Can Safely Evaluate and Revaccinate Individuals With Immediate Allergic Reactions to mRNA COVID-19 Vaccines
por: Greenhawt, Matthew, et al.
Publicado: (2021)

School Attendance, Asthma Risk, and COVID-19 in Children
por: Abrams, Elissa M., et al.
Publicado: (2021)

Risk Communication During COVID-19
por: Abrams, Elissa M., et al.
Publicado: (2020)

A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies
por: Shaker, Marcus, et al.
Publicado: (2021)

The COVID-19 pandemic: Adverse effects on the social determinants of health in children and families
por: Abrams, Elissa M., et al.
Publicado: (2022)

COVID-19 vaccines: addressing hesitancy in young people with allergies
por: Abrams, Elissa M, et al.
Publicado: (2021)

What the COVID-19 Pandemic Can Teach Us About Resource Stewardship and Quality in Health Care
por: Abrams, Elissa M., et al.
Publicado: (2021)

Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times
por: Shaker, Marcus S., et al.
Publicado: (2020)

The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19
por: Abrams, Elissa M., et al.
Publicado: (2020)

The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World
por: Greenhawt, Matthew, et al.
Publicado: (2021)

Association of Fatality Risk With Value-Based Drug Pricing of Epinephrine Autoinjectors for Children With Peanut Allergy: A Cost-effectiveness Analysis
por: Shaker, Marcus, et al.
Publicado: (2018)

Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada
por: Abrams, Elissa M., et al.
Publicado: (2021)

Estimation of Health and Economic Benefits of a Small Automatic External Defibrillator for Rapid Treatment of Sudden Cardiac Arrest (SMART): A Cost-Effectiveness Analysis
por: Shaker, Marcus S., et al.
Publicado: (2022)

Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”
por: Shaker, Marcus S., et al.
Publicado: (2021)

Novel Approaches to Food Allergy Management During COVID-19 Inspire Long-Term Change
por: Mack, Douglas P., et al.
Publicado: (2020)

The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis
por: Shaker, Marcus, et al.
Publicado: (2021)

Determining Levers of Cost-effectiveness for Screening Infants at High Risk for Peanut Sensitization Before Early Peanut Introduction
por: Greenhawt, Matthew, et al.
Publicado: (2019)

Mitigating Misinformation and Changing the Social Narrative
por: Abrams, Elissa M., et al.
Publicado: (2020)

Keeping risk in context while rethinking the setting of asthma biologics in patient-centered care
por: Greenhawt, Matthew, et al.
Publicado: (2020)

Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness Analysis
por: Shaker, Marcus, et al.
Publicado: (2019)

The Children of Risk Communication
por: Paakkari, Leena, et al.
Publicado: (2022)

Vaccines are not yet a silver bullet: The imperative of continued communication about the importance of COVID-19 safety measures
por: Su, Zhaohui, et al.
Publicado: (2021)

Media Influence on Anxiety, Health Utility, and Health Beliefs Early in the SARS-CoV-2 Pandemic—a Survey Study
por: Greenhawt, Matthew, et al.
Publicado: (2021)

Managing Food Allergy in Schools During the COVID-19 Pandemic
por: Greenhawt, Matthew, et al.
Publicado: (2020)

PEG/Polysorbate Skin Testing Has No Utility in the Assessment of Suspected Allergic Reactions to SARS-CoV-2 Vaccines
por: Greenhawt, Matthew, et al.
Publicado: (2021)

Walking the Tightrope: Reevaluating science communication in the era of COVID-19 vaccines
por: Dudley, Matthew Z., et al.
Publicado: (2021)

Risk Communication and Community Engagement During the Migrant Worker COVID-19 Outbreak in Singapore
por: Tam, Wai Jia, et al.
Publicado: (2021)

Effective Communication at Different Phases of COVID-19 Prevention: Roles, Enablers and Barriers
por: Mohd Hanafiah, Khayriyyah, et al.
Publicado: (2021)

Culture Matters in Communicating the Global Response to COVID-19
por: Airhihenbuwa, C.O., et al.
Publicado: (2020)

Communication in the Toronto critical care community: important lessons learned during SARS
por: Booth, Christopher M, et al.
Publicado: (2003)

Smoke evacuation, is it important for prevention of COVID‐19?
por: Zhaori, Getu
Publicado: (2020)

The Importance of Video Visits in the Time of COVID‐19
por: Lindsay, Jan A., et al.
Publicado: (2020)

The importance of science-informed policy and what the data really tell us about e-cigarettes
por: Abrams, David B., et al.
Publicado: (2015)

COVID-19 Vaccines for Adolescents: Leveraging the ABCs of Communication
por: Hoffman, Beth L., et al.
Publicado: (2021)

People at heightened risk of deterioration from COVID-19: living ‘with’ or living ‘despite’ public health communications?
por: Ryan, Rebecca, et al.
Publicado: (2023)

Reply to “Challenges to pediatric services during COVID-19 pandemic: A London, UK perspective”
por: Bansal, Priya, et al.
Publicado: (2020)

Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist
por: Bansal, Priya, et al.
Publicado: (2020)

COVID-19, conflict, and non-communicable diseases among refugees
por: Al-Oraibi, Amani, et al.
Publicado: (2021)

Mental health consequences of COVID-19 media coverage: the need for effective crisis communication practices
por: Su, Zhaohui, et al.
Publicado: (2021)

Non-communicable Diseases and COVID-19; a double-edged sword A Special Communication from IRAN
por: Peykari, Niloofar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k78kjoukd50ovflcr0ssh4aakn